•
Dec 31, 2020

Molson Coors Q4 2020 Earnings Report

reported fourth quarter and full year results and reinstated guidance for 2021.

Key Takeaways

Molson Coors reported a decrease in net sales revenue by 7.7% and a net loss of $1.4 billion for the fourth quarter of 2020, primarily driven by declines in Europe and Canada due to coronavirus pandemic restrictions and a $1.5 billion Europe goodwill impairment charge. However, U.S. net sales revenue increased by 1.9%. The company is reinstating financial guidance for 2021 and expects to reinstate a dividend in the second half of the year.

Net Sales Revenue decreased 7.7% reported and 8.3% in constant currency, primarily driven by Europe and Canada declines resulting from restrictions in the on-premise channel as a result of the coronavirus pandemic.

Net Sales Revenue in the U.S. increased 1.9%, on a brand volume basis, partially offsetting the Europe and Canada results.

U.S. GAAP Net Loss of $1.4 billion ($6.32 per share) primarily driven by $1.5 billion Europe goodwill impairment charge.

Non-GAAP EPS of $0.40 decreased 60.8%.

Total Revenue
$2.29B
Previous year: $2.49B
-7.7%
EPS
$0.4
Previous year: $1.02
-60.8%

Molson Coors

Molson Coors

Molson Coors Revenue by Segment

Forward Guidance

Molson Coors expects a mid-single digit increase in net sales revenue on a constant currency basis and approximately flat underlying EBITDA compared to 2020. The company intends to maintain its investment grade rating and expects to achieve a net debt to underlying EBITDA ratio of approximately 3.25x by the end of 2021 and below 3.0x by the end of 2022. The company also expects to reinstate a dividend in the second half of 2021.

Positive Outlook

  • Net sales revenue: mid-single digit increase on a constant currency basis.
  • Deleverage: We intend to maintain our investment grade rating as demonstrated by our continued deleveraging.
  • We expect to achieve a net debt to underlying EBITDA ratio of approximately 3.25x by the end of 2021 and below 3.0x by the end of 2022.
  • Underlying depreciation and amortization: approximately $800 million.
  • Underlying effective tax rate: in the range of 20% to 23% for 2021.

Challenges Ahead

  • While uncertainty remains regarding the coronavirus pandemic, including the timing and strength of the recovery, we currently expect the following for full year 2021, which we consider a year of investment
  • Underlying EBITDA: approximately flat compared to 2020 on a constant currency basis.
  • Consolidated net interest expense: approximately $270 million, plus or minus 5%.
  • Unspecified impacts of the coronavirus pandemic
  • Uncertainty regarding the timing and strength of the recovery.